Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, announced today that its investigational therapy, PP-007 (PEGylated carboxyhemoglobin, bovine), has received Breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results